4,4′-Bis(2-pyridyl)-3,3′-bi-1,2,5-thia­diazo­le

The title compound, C₁₄H₈N₆S₂, crystallizes with the planes of the two central 1,2,5-thia­diazo­le rings orthogonal and with the pyridine rings approximately coplanar with their attached 1,2,5-thia­diazo­le rings.     

A novel heterocyclic sulfon­amide: N‐benzyl‐5‐[N‐benzyl‐N‐(tert‐butyl­oxy­carbonyl)­amino]‐N‐(tert‐butyl­oxycarbonyl)‐1,3,4‐thia­diazo­le‐2‐sulfon­amide

The title compound, C₂₆H₃₂N₄O₆S₂, is a heterocyclic sulfon­amide which is a 1,3,4‐thia­diazo­le derivative. Structural data for this compound are compared with those of related compounds.     

Crystalline and Molecular Structure of 2-Amino-5-phenyl-1,3,4-thiadiazole

The crystalline and molecular structure of 2-amino-5-phenyl-1,3,4-thiadiazole was studied by the X-ray diffraction method. C₈H₇N₃S. Monoclinic crystals: a = 11.085(3), b = 7.544(3), c = 11.180(3) Å; = 115.22(2)°; V = 845.8(5) ų; dcalc = 1.404 g/cm³; (MoK ) = 0.325 mm^{- 1}; Z = 4; space group P2₁/c. Molecules of 2-amino-5-phenyl-1,3,4-thiadiazole in crystal form dimers through intermolecular hydrogen bonds, which are arranged in infinite layers parallel to the xy plane.     

Two 2,5‐bis(2‐pyridinyl)‐1,3,4‐oxa­diazo­le–metal complexes (M = Cu and Ni)

The reaction of the diazine ligand 3,5‐bis(2‐pyridinyl)‐1,3,4‐oxa­diazole (pod, C₁₂H₈N₄O), with Cu(CF₃SO₃)₂ or Ni(ClO₄)₂ afforded the title complexes di­aqua­bis­[3,5‐bis(2‐pyridinyl)‐1,3,4‐oxa­diazole‐N²,N³]copper(II) bis­(tri­fluoro­methane­sul­fon­ate), [Cu(pod)₂(H₂O)₂](CF₃SO₃)₂, and di­aqua­bis­[3,5‐bis(2‐pyridinyl)‐1,3,4‐oxa­diazo­le‐N²,N³]­nickel(II) diperchlorate, [Ni(pod)₂(H₂O)₂](ClO₄)₂. Both complexes present a crystallographically centrosymmetric mononuclear cation structure which consists of a six‐coordinated Cu^II or Ni^II ion with two pod mol­ecules acting as bidentate ligands and two axially coordinated water mol­ecules.     

4,7‐Bis(4‐pyridyl­ethynyl)‐2,1,3‐benzo­thia­diazo­le and its dipyridinium diperchlorate

The title compound, C₂₀H₁₀N₄S, and its dipyridinium salt, 4,4′‐(2,1,3‐benzo­diazol‐4,7‐diyl­diethynyl)­dipyridinium diperchlorate, C₂₀H₁₂N₄S²⁺·2ClO₄^?, display bond alternation in the 2,1,3‐benzo­thia­diazo­le rings, which suggests their quinonoid character. The dipyridinium dication mol­ecules stack along the a axis and form a dimer with short S?N interheteroatom contacts [3.146 (4) Å] between the two 1,2,5‐thia­diazo­le rings. The dimer is surrounded by the perchlorate anions with which it forms a large number of intermolecular N—H?O and C—H?O hydrogen bonds.     

Novel heterocyclic inhibitors of matrix metalloproteinases: three 6H‐1,3,4‐thiadiazines

The title compounds, (2S)‐N‐[5‐(4‐chloro­phenyl)‐2,3‐di­hydro‐6H‐1,3,4‐thia­diazin‐2‐yl­idene]‐2‐[(phenyl­sulfonyl)­amino]­pro­pan­amide, C₁₈H₁₇ClN₄O₃S₂, (I), (2R)‐N‐[5‐(4‐fluoro­phenyl)‐6H‐1,3,4‐thia­diazin‐2‐yl]‐2‐[(phenyl­sulfonyl)amino]­propan­amide, C₁₈H₁₇FN₄O₃S₂, (II), and (2S)‐N‐[5‐(5‐chloro‐2‐thienyl)‐6H‐1,3,4‐thia­diazin‐2‐yl]‐2‐[(phenyl­sulfonyl)­amino]­propan­amide, C₁₆H₁₅ClN₄O₃S₃, (III), are potent inhibitors of matrix metalloproteinases. In all three compounds, the thia­diazine ring adopts a screw‐boat conformation. The mol­ecules of compound (I) show a short intramolecular N_Ala—H?N_exo hydrogen bond [N?N 2.661 (3) Å] and are linked into a chain along the c axis by N_endo—H?S_endo and N_endo—H?O_Ala hydrogen bonds [N?S 3.236 (3) and N?O 3.375 (3) Å] between neighbouring mol­ecules. In compound (II), the mol­ecules are connected antiparallel into a chain along the a axis by N_exo—H?O_Ala and N_Ala—H?N_endo hydrogen bonds [N?O 2.907 (6) and N?N 2.911 (6) Å]. The mol­ecules of compound (III) are dimerized antiparallel through N_exo—H?N_endo hydrogen bonds [N?N 2.956 (7) and 2.983 (7) Å]. The different hydrogen‐bonding patterns can be explained by an amido–imino tautomerism (prototropic shift) shown by different bond lengths within the 6H‐1,3,4‐thia­diazine moiety.     

1‐{5‐[2‐(Tri­fluoro­methyl)­phenyl]‐1,3,4‐thia­diazol‐2‐yl}guanidinium chloride

In the title compound, C₁₀H₉F₃N₅S⁺·Cl^?, which was developed as a potential anticonvulsant, the phenyl ring, the thia­diazo­le ring and the guanidinium moiety are all planar. There is a dihedral angle of 48.9 (1)° between the thia­diazole and phenyl rings which prevents steric hindrance arising from the π bonds within the former, and the tri­fluoro­phenyl moiety attached to the latter. The thia­diazole and guanidinium moieties are twisted by 12.7 (2)° with respect to each other. An extensive network of hydrogen bonds, predominantly involving the chloride ion, maintains the crystal structure.     

Cyclic condensations of 2-amino-1,3,4-thiadiazole with 1,3-dicarbonyl compounds

The reactions of 2-amino-1,3,4-thiadiazole with 1,3-dicarbonyl compounds are described. 2,4-Pentanedione gave 2-thiocyanato-4,6-dimethylpyrimidine while diethylmalonate and ethyl acetoacetate yielded 5-hydroxy-7H-1,3,4-thiadiazolo[3,2-a]pyrimidin-7-one and 7-methyl-5H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one, respectively. The structure of the latter compound was confirmed by a synthesis of the alternative isomeric structure (5-methyl-7H-1,3,4-thiadiazolo[3,2-a]pyrirnidin-7-one) from 2-amino-1,3,4-thiadiazole and α-bromocrotonic acid.     

KNI-272, a highly selective and potent peptidic HIV protease inhibitor

Kynostatin {KNI-272; systematic name: 3-[3-benzyl-2-hydroxy-9-(isoquinolin-5-yl­oxy)-6-methyl­sulfanyl­methyl-5,8-dioxo-4,7-di­aza­nonanoyl]-N-tert-butyl-1,3-thia­zolane-4-carbox­amide}, a highly selective and potent HIV protease inhibitor containing allo­phenyl­norstatin [(2S,3S)-3-amino-2-hydroxy-4-phenyl­butyric acid], has been crystallized as the hydrate, C₃₃H₄₁N₅O₆S₂·0.803H₂O, from aqueous hexyl­ene glycol. The observed disorder of the phenyl group in the structure is related to the mode of hydration. The backbone conformation of the mol­ecule is twisted and the overall conformation of the free inhibitor is similar to that observed in its complex with HIV protease.     

(BETS)2[Fe(tdas)2]2: a new metal in the molecular conductor family

The structure of bis­[4,5‐ethyl­enedi­thio‐2‐(4,5‐ethyl­enedi­thio‐1,3‐diselena­cyclo­pent‐4‐en‐2‐yl­idene)‐1,3‐diselena­cyclo­pent‐4‐enium] bis(μ‐1,2,5‐thia­diazo­le‐3,4‐di­thiol­ato‐κ³S⁴,S⁵:S⁴)bis[(1,2,5‐thia­diazo­le‐3,4‐di­thiol­ato‐κ²S⁴,S⁵)­iron(III)], (BETS)₂[Fe(tdas)₂]₂ [BETS is alternatively called bis­(ethyl­enedi­thio)­tetraselenafulvalenium] or (C₁₀H₈S₄Se₄)₂[{Fe(C₂N₂S₃)₂}₂], consists of segregated columns of dimers of BETS and columns of dimers of [Fe(tdas)₂]. Each dimer displays inversion symmetry. Numerous chalcogen–chalcogen contacts are observed within and between the columns, producing a network of interactions responsible for the metal‐like behaviour of the compound.     

Acylation of 5-amino-3H-1,3,4-thiadiazolin-2-one

Acylation of 5-amino-3H-1,3,4-thiadiazolin-2-one (2) was undertaken selectively at either the 3-NH position or at 5-amino group depending on reaction conditions. The 3-NH is highly acidic and acylation takes place with acid anhydrides at this position in high yields in the presence of pyridine or triethylamine. The diacylation of both the 3-position and the 5-amino group was only possible via the 5-amino-3-acyl-1,3,4-thiadiazolin-2-one intermediates 4 . Under neutral conditions, acylation only occurs at the 5-amino group with acyl chlorides forming 5-acylamino-3H-1,3,4-thiadiazolin-2-ones 5 . 5-Acetylamino-3H-1,3,4-thiadiazolin-2-one can also be synthesized by the thermal transformation of 5-amino-3-acetyl-1,3,4-thiadi-azolin-2-one in acetic acid.     

Tetragonal-pyramidal complex of copper nitrate with 2-Amino-5-ethyl-1,3,4-thiadiazole

A complex compound of Cu(II) nitrate with 2-amino-5-ethyl-1,3,4-thiadiazole was synthesized and its structure was studied by the methods of IR spectroscopy and X-ray crystal analysis. The complex has the composition Cu(NO₃)₂(2-amino-5-ethyl-1,3,4-thiadiazole)₄ with four molecules of the heterocyclic ligand (coordination through nitrogen atoms of thiadiazole rings) and one of nitrate ions (the other is replaced in the second sphere) entering into the coordination sphere of the complex polyhedron. The internal coordination sphere of the complex has the form of a tetragonal pyramid with 2-amino-5-ethyl-1,3,4-thiadiazole ligands in the sites of its base and the oxygen atom of the nitrate ion in a slightly distorted vertex of the pyramid.     

2‐Amino derivatives of 5‐nitro­phenyl­acet­amide

The structures of the potential non‐linear optical (NLO) materials N‐[2‐(iso­propyl­amino)‐5‐nitro­phenyl]­acet­amide, (I) C₁₁H₁₅N₃O₃, and N‐[2‐(butyl­amino)‐5‐nitro­phenyl]­acet­amide, (II) C₁₂H₁₇N₃O₃, have been investigated by X‐ray analysis. To compare them with the structure of N‐[2‐(di­methyl­amino)‐5‐nitro­phenyl]­acet­amide, (III) C₁₀H₁₃N₃O₃, a known NLO compound, we had to redetermine the structure of (III), since it was described only briefly in the literature. There are two mol­ecules in the asymmetric unit of compound (I), which have different orientations of the substituents with respect to the benzene ring. The packing of mol­ecules in (II) and (III) contains stacks but both (I) and (II) crystallize in a centrosymmetric space group, which renders them inappropriate for NLO applications.     

Polymorphism of 3‐(5‐phenyl‐1,3,4‐oxadiazol‐2‐yl)‐ and 3‐[5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazol‐2‐yl]‐2H‐chromen‐2‐ones

This study of 3‐(5‐phenyl‐1,3,4‐oxadiazol‐2‐yl)‐2H‐chromen‐2‐one, C₁₇H₁₀N₂O₃, 1 , and 3‐[5‐(pyridin‐4‐yl)‐1,3,4‐oxadiazol‐2‐yl]‐2H‐chromen‐2‐one, C₁₆H₉N₃O₃, 2 , was performed on the assumption of the potential anticancer activity of the compounds. Three polymorphic structures for 1 and two polymorphic structures for 2 have been studied thoroughly. The strongest intermolecular interaction is stacking of the `head‐to‐head' type in all the studied crystals. The polymorphic structures of 1 differ with respect to the intermolecular interactions between stacked columns. Two of the polymorphs have a columnar or double columnar type of crystal organization, while the third polymorphic structure can be classified as columnar‐layered. The difference between the two structures of 2 is less pronounced. Both crystals can be considered as having very similar arrangements of neighbouring columns. The formation of polymorphic modifications is caused by a subtle balance of very weak intermolecular interactions and packing differences can be identified only using an analysis based on a study of the pairwise interaction energies.     

Optimized POCl3-assisted synthesis of 2-amino-1,3,4-thiadiazole/1,3,4-oxadiazole derivatives as anti-influenza agents

Although recent decades have witnessed the synthesis of 1,3,4-thiadiazoles via phosphorus POCl₃-promoted cyclization reaction, simultaneous access to 2-amino-1,3,4-thiadiazole and 2-amino-1,3,4-oxadiazole analogs remains unexpected and elusive. Herein, a detailed regiocontrolled synthesis of 2-amino-1,3,4-thiadiazoles in good to high yields with good regioselectivities from readily available thiosemicarbazides using POCl₃ was disclosed. Meantime, to establish a comprehensive structure–activity relationship, 2-amino-1,3,4-oxadiazole derivatives as single regioisomers were prepared via EDCI·HCl-triggered cyclization of the thiosemicarbazide intermediates. The in vitro anti-influenza assays proved that the selected compounds with the pyrazine/pyridine ring exhibited certain inhibitory activities against influenza A virus strains A/HK/68 (H3N2) and A/PR/8/34 (H1N1) in MDCK cells. Among them, N-(adamantan-1-yl)-5-(5-(azepan-1-yl)pyrazin-2-yl)-1,3,4-thiadiazol-2-amine (4j) was the most active compound, and exhibited favorable activity with EC₅₀ values of 3.5 μM and 7.5 μM, respectively. In addition, the molecular docking results explained the reason why compound 4j had dual inhibitory activity and revealed the reasonable binding mode of this compound with the M2-S31N and M2-WT ion channels. This compound had the potential to be further developed as an anti-influenza drug.     

The different modes of chiral [1,2,3]triazolo[5,1‐b][1,3,4]thiadiazines: crystal packing,conformation investigation and cellular activity

The crystal structures of four new chiral [1,2,3]triazolo[5,1‐b][1,3,4]thiadiazines are described, namely, ethyl 5′‐benzoyl‐5′H,7′H‐spiro[cyclohexane‐1,6′‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine]‐3′‐carboxylate, C₁₉H₂₂N₄O₃S, ethyl 5′‐(4‐methoxybenzoyl)‐5′H,7′H‐spiro[cyclohexane‐1,6′‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine]‐3′‐carboxylate, C₂₀H₂₄N₄O₄S, ethyl 6,6‐dimethyl‐5‐(4‐methylbenzoyl)‐6,7‐dihydro‐5H‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine‐3‐carboxylate, C₁₇H₂₀N₄O₃S, and ethyl 5‐benzoyl‐6‐(4‐methoxyphenyl)‐6,7‐dihydro‐5H‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine‐3‐carboxylate, C₂₁H₂₀N₄O₄S. The crystallographic data and cell activities of these four compounds and of the structures of three previously reported similar compounds, namely, ethyl 5′‐(4‐methylbenzoyl)‐5′H,7′H‐spiro[cyclopentane‐1,6′‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine]‐3′‐carboxylate, C₁₉H₂₂N₄O₃S, ethyl 5′‐(4‐methoxybenzoyl)‐5′H,7′H‐spiro[cyclopentane‐1,6′‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine]‐3′‐carboxylate, C₁₉H₂₂N₄O₄S, and ethyl 6‐methyl‐5‐(4‐methylbenzoyl)‐6‐phenyl‐6,7‐dihydro‐5H‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine‐3‐carboxylate, C₂₂H₂₂N₄O₃S, are contrasted and compared. For both crystallization and an MTT assay, racemic mixtures of the corresponding [1,2,3]triazolo[5,1‐b][1,3,4]thiadiazines were used. The main manner of molecular packing in these compounds is the organization of either enantiomeric pairs or dimers. In both cases, the formation of two three‐centre hydrogen bonds can be detected resulting from intramolecular N—H…O and intermolecular N—H…O or N—H…N interactions. Molecules of different enantiomeric forms can also form chains through N—H…O hydrogen bonds or form layers between which only weak hydrophobic contacts exist. Unlike other [1,2,3]triazolo[5,1‐b][1,3,4]thiadiazines, ethyl 5′‐benzoyl‐5′H,7′H‐spiro[cyclohexane‐1,6′‐[1,2,3]triazolo[5,1‐b][1,3,4]thiadiazine]‐3′‐carboxylate contains molecules of only the (R)‐enantiomer; moreover, the N—H group does not participate in any significant intermolecular interactions. Molecular mechanics methods (force field OPLS3e) and the DFT B3LYP/6‐31G+(d,p) method show that the compound forming enantiomeric pairs via weak N—H…N hydrogen bonds is subject to greater distortion of the geometry under the influence of the intermolecular interactions in the crystal. For intramolecular N—H…O and S…O interactions, an analysis of the noncovalent interactions (NCIs) was carried out. The cellular activities of the compounds were tested by evaluating their antiproliferative effect against two normal human cell lines and two cancer cell lines in terms of half‐maximum inhibitory concentration (IC₅₀). Some derivatives have been found to be very effective in inhibiting the growth of Hela cells at nanomolar and submicromolar concentrations with minimal cytotoxicity in relation to normal cells.     

2,5‐Diaryl‐1,3,4‐selenadiazoles prepared from Woollins' reagent

Two polymorphs of 2,5‐diphenyl‐1,3,4‐selenadiazole, C₁₄H₁₀N₂Se, denoted (Ia) and (Ib), and a new polymorph of 2,5‐bis(thiophen‐2‐yl)‐1,3,4‐selenadiazole, C₁₀H₆N₂S₂Se, (IIb), form on crystallization of the compounds, prepared using Woollins' reagent (2,4‐diphenyl‐1,3‐diselenadiphosphetane 2,4‐diselenide). These compounds, along with 2‐(4‐chlorophenyl)‐5‐phenyl‐1,3,4‐selenadiazole, C₁₄H₉ClN₂Se, (III), and 2‐(furan‐2‐yl)‐5‐(p‐tolyl)‐1,3,4‐selenadiazole, C₁₃H₁₀N₂OSe, (IV), show similar intermolecular interactions, with π–π stacking, C—H...π interactions and weak hydrogen bonds typically giving rise to molecular chains. However, the combination of interactions differs in each case, giving rise to different packing arrangements. In polymorph (Ib), the molecule lies across a crystallographic twofold rotation axis, and (IV) has two independent molecules in the asymmetric unit.     

Copper(II) complexes of 2-amino-1,3,4-thiadiazole and 2-ethylamino-1,3,4-thiadiazole

Summary Some copper(II) complexes of 2-amino-1,3,4-thiadiazole (atz) and 2-ethylamino-1,3,4-thiadiazole (eatz) have been prepared and studied by electronic, i.r. and e.p.r. spectra and by magnetochemical and conductometric methods. The CuX₂ · atz (X=Cl, Br) and CuCl₂ · eatz complexes are presumably six-coordinate with bridging ligand molecules and asymmetrically bridging halide ions, while the CuX₂ · 2 atz (X=Cl, Br) complexes probably have a flattened tetrahedral N₂X₂ moiety with apical interactions. The CuBr₂ · 5/3 eatz · 2/3 MeOH and Cu(OAc)₂ · L (L=atz or eatz) complexes have subnormal magnetic moments (1.53-1.40 B.M.). The acetato-complexes have a dimeric structure with bridging acetato-groups, copper-copper interactions and apical ligand molecules. The ligands bond principally through the amine nitrogen atom and, when bridging, also through one ring-nitrogen.     

Synthesis and characterization of a Cu(II) complex of 2-benzylmercapto-5-methyl-1,3,4-thiadiazole (C10H10N2S2)

A Cu(II) complex of 2-benzylmercapto-5-methyl-1,3,4-thiadiazole was synthesized and characterized. The crystal structure of the copper complex and the free ligand were determined by single-crystal X-ray diffraction at room temperature: {[Cu(C₁₀H₁₀N₂S₂)₂(Cl)₂], P 1 triclinic, a = 8.1450(2) Å, b = 8.1690(2) Å, c = 10.8180(3) Å, α = 97.4040(12)°, β = 101.6270(11)°, γ = 116.1431(14)°; C₁₀H₁₀N₂S₂ ligand, Pbca orthorhombic, a = 8.7938(7) Å, b = 9.6491(7) Å, c = 25.3552(18) Å}. The metal complex framework consists of discrete units that provide crystalline stability through a network of van der Waals contacts. The Cu(II) is coordinated by two chloride ions and two 2-benzylmercapto-5-methyl-1,3,4-thiadiazole monodentate ligands showing a distorted square planar configuration. Both thiadiazole ligands coordinate through the N atom bonded to the benzylthio substituted C atom.

The FTIR spectroscopic data are consistent with this structural model. Analysis of the magnetic susceptibility from 5 K to room temperature indicates the presence of paramagnetic Cu(II), confirmed by the EPR spectrum.     

Some Diels–Alder adducts of 6-vinyl-1-oxa-4-thiaspiro[4.5]dec-6-ene

6-Vinyl-1-oxa-4-thia­spiro­[4.5]­dec-6-ene has been reacted with dienophiles, such as N-phenyl­male­imide (NPM), N-methyl­triazoline-2,5-dione (MTAD) and di­methyl­acetyl­ene di­carboxyl­ate (DMAD), to assess the 1,3-diastereofacial selection caused by the acetal function. In each case, a mixture of two diastereoisomers was produced. The crystal structures of the products of the addition of NPM and MTAD syn to the acetal oxy­gen, 2-phenyl-2,3,3a,4,5,5a,6,7,8,9,9a,9b-dodeca­hydro-1H-benz­[e]­iso­indole-6-spiro-2′-[1′,3′]­oxa­thiol­ane-1,3-dione, C₂₀H₂₁NO₃S, (IIa), and 2-methyl-5,7,8,9,10,10a-hexa­hydro-1H-1,2,4-triazolo­[1,2-a]­cinnoline-7-spiro-2′-[1′,3′]­oxa­thiol­ane-1,3-dione, C₁₃H₁₇N₃O₃S, (IIIa), respectively, and the product of the addition of DMAD syn to the acetal sulfur, di­methyl 1,2,3,4,4a,7-hexa­hydro­naphthalene-1-spiro-2′-[1′,3′]­oxa­thiol­ane-5,6-di­carboxyl­ate, C₁₆H₂₀O₅S, (IVb), have been determined. All three structures are composed of independent mol­ecules separated by normal van der Waals distances. The 1-oxa-4-thia heterocyclic ring has an envelope conformation in the three structures and the S—Csp³ bond distances differ significantly from each other, as observed in comparable structures; the remaining molecular dimensions are as expected.